Digestive enzyme supplements: who actually needs them, and who's wasting money

What a digestive enzyme actually is

Your body runs on enzymes that cut food into pieces small enough to absorb. Three families do most of the work: amylases break down starch, proteases break down protein, and lipases break down fat. Most of these come from your pancreas, which secretes them into the small intestine on cue every time you eat; your saliva and gut lining add a few more. In a healthy person, this system is generously over-built — the pancreas makes far more enzyme than a normal meal strictly requires. That single fact is the hinge the entire enzyme-supplement question turns on.

A supplement labeled "digestive enzymes" is an attempt to add more of these from the outside. The products split cleanly into two groups, even though the marketing blurs them. On one side are single, targeted enzymes: lactase to break down the milk sugar lactose, or alpha-galactosidase to break down the specific fibers in beans that your own enzymes can't touch. On the other side are broad-spectrum blends — a scoop of amylase, protease, and lipase, often with a dozen other plant- or fungus-derived enzymes — sold for "digestion," "bloating," or "gut support" in general. The first group solves a defined problem. The second is solving for a feeling, and that is where the evidence gets thin.

It is worth naming one regulatory fact up front, without making it the whole story: in North America, over-the-counter enzyme blends are sold as supplements, not drugs. That means the potency in the jar is not held to the standard a prescription enzyme is, and the units printed on the label can vary from what is actually delivered. Prescription pancreatic enzymes, by contrast, are an approved medication with a defined dose. Same word on the front; very different things inside.

The supplement aisle sells one word for two products: a targeted enzyme that fixes a specific, diagnosable problem, and a broad blend that promises to fix a vague one. Only the first reliably delivers.

The real medicine: when the pancreas can't keep up

Start with the strongest case, because it is genuinely strong. Some people's pancreas can no longer secrete enough enzyme to digest a meal — a condition called exocrine pancreatic insufficiency (EPI). It is not vague bloating; it is measurable maldigestion. The usual causes are chronic pancreatitis in adults, cystic fibrosis in children — where roughly 85% of patients are pancreatic-insufficient from early in life — and the aftermath of pancreatic surgery or pancreatic cancer.¹ The signal these patients send the gut is too weak to finish the job, and the consequences are real: greasy, foul, hard-to-flush stools (steatorrhea), weight loss, and fat-soluble vitamin deficiencies as fat passes through undigested.

EPI is diagnosed, not guessed. The standard first test is fecal elastase, an enzyme measured in a stool sample; a level below 100 µg/g is good evidence of insufficiency, with 100–200 µg/g an indeterminate grey zone.¹ This matters because it draws the bright line in this whole article: the people who benefit most from enzyme replacement are the ones who have been tested and found deficient, not the ones who feel puffy after pasta.

For those patients, pancreatic enzyme replacement therapy (PERT) — prescription capsules of pancreatin, an enteric-coated mix of lipase, protease, and amylase taken with every meal and snack — is the mainstay of treatment, and the evidence behind it is robust. A systematic review and meta-analysis in Gut pooled 17 randomized controlled trials and 511 patients with chronic pancreatitis. PERT significantly improved the coefficient of fat absorption — the share of dietary fat the body actually takes up — from roughly 63% up to 84% versus baseline, with parallel gains in protein absorption and reductions in fecal fat, fecal weight, and abdominal pain, all without significant adverse events.² This is not a wellness nicety. It corrects malnutrition, and in advanced pancreatic disease it is tied to better nutritional status and survival. If you have diagnosed EPI, enzymes are not optional, and nothing in this article's skepticism about the blends applies to you.

The useful middle: one enzyme, one job

Between life-saving prescription and oversold blend sits a genuinely useful tier: a single enzyme matched to a specific intolerance. You are not topping up a broken pancreas here. You are handing your gut one tool it never had, to break down one substance it was never equipped to break down. The logic is clean and so, mostly, is the evidence.

Lactase for lactose. Lactose intolerance is the textbook case. People who lose the lactase enzyme after childhood can't split milk sugar, so it ferments in the colon and produces gas, cramps, and diarrhea. Taking lactase with dairy supplies the missing tool directly. In a randomized, double-blind, placebo-controlled crossover trial of 47 adults with confirmed lactose intolerance, taking lactase with a lactose load cut the cumulative hydrogen breath level — an objective marker of unfermented lactose reaching the colon — by about 55% over three hours, with significantly improved symptom scores.³ One honest caveat the data also shows: these supplements work best at moderate lactose loads and get less reliable as the dose climbs, so they are a tool for managing dairy, not a license to ignore it entirely.

Alpha-galactosidase for beans. The gas from beans, lentils, and cruciferous vegetables comes largely from a family of fibers (raffinose-type oligosaccharides) that human enzymes can't digest at all — so they reach the colon intact and feed gas-producing bacteria. The enzyme alpha-galactosidase, sold as Beano, breaks those fibers down before they get there. In the original double-blind crossover trial, subjects eating a meatless chili test meal had significantly fewer flatulence events per hour on the enzyme than on placebo.⁴ The same trial is a fair-minded example of not overclaiming: the benefit was clearest for flatulence, and the study did not show significant separation for bloating or abdominal pain. So: real, specific, and bounded — it targets the gas, not every symptom.

The throughline for this tier is the word specific. These enzymes work because each is matched to one substance the user has a defined problem with. That is the opposite of the blend model, where a generic mix is pitched at a generic symptom — and it is exactly why this middle tier holds up and the next one doesn't.

The oversold part: blends for everyday bloating

Now the part the house voice exists for. Walk into any supplement shop and the best-selling "digestive enzymes" are not single-target tools — they are broad-spectrum blends marketed to the large population of generally healthy people who feel bloated, gassy, or heavy after meals and want to feel better. For that use, the evidence is weak and inconsistent, and the reason is the over-built pancreas we started with: a healthy person already makes far more amylase, protease, and lipase than a meal needs. Adding more to a system that isn't short doesn't have an obvious problem to solve.

It would be unfair to say there is no supporting data, so here is the best of it, stated honestly. A 2023 randomized, double-blind, placebo-controlled trial of 120 people with functional dyspepsia — a diagnosed disorder of chronic indigestion, not general bloating — found that a fungal multi-enzyme blend over two months improved quality-of-life, pain, and sleep scores versus placebo.⁵ That is a real positive result, and it is why this claim is graded weak rather than hype. But notice the boundaries: it is a single trial, in a defined clinical condition, of one specific product. It is not evidence that a generic blend fixes the everyday post-dinner bloat in someone with a normal gut, and it does not generalize from that one product to the next jar on the shelf. For broad bloating and IBS-type symptoms in otherwise healthy people, the trials are few, the results mixed, and the effect — where it appears — modest.

The deeper issue is mechanism. Bloating in a healthy person is usually not a maldigestion problem at all. It is more often about gut motility, visceral sensitivity, or which fermentable fibers you ate — none of which an extra dose of pancreatic enzyme reliably touches. When the problem isn't "I can't break this food down," adding break-it-down enzymes is aiming at the wrong target. That is the unglamorous reason the blends underperform their marketing: they treat a digestion problem that, for most buyers, isn't the actual problem.

If your bloating tracks with specific trigger foods, the higher-yield move is usually to identify and manage those foods — the same logic behind a structured low-FODMAP approach — rather than to blanket every meal with a generic enzyme scoop. Our gut and digestion hub maps the foundational levers that tend to move bloating more reliably than a blend does.

The hype layer: leaky gut, detox, absorption

Above the oversold-but-plausible blend claims sits a layer that crosses into outright hype, and it deserves to be named plainly. Enzyme products are routinely marketed as a way to "heal leaky gut," "support detoxification," and "boost nutrient absorption" in healthy people. There is no credible human trial evidence that swallowing digestive enzymes does any of these things in someone with a normally functioning gut.

Take absorption. In a healthy person, nutrient absorption is not being throttled by an enzyme shortage — the pancreas already supplies more than enough.¹ Adding more enzyme to an adequate system does not push absorption higher; there is no deficit for it to correct. "Boosts absorption" borrows the language of EPI treatment — where correcting a real deficiency genuinely restores absorption — and quietly applies it to people who don't have the deficiency. That is the sleight of hand: a true claim about sick pancreases, recycled as a benefit for healthy ones.

"Leaky gut" and "detox" are looser still. "Leaky gut" as a consumer term outruns what the science of intestinal permeability actually supports, and there is no trial showing an oral enzyme blend seals a gut barrier or accelerates any "detox" pathway in a healthy adult. The liver and kidneys handle detoxification; they do not need an enzyme capsule's help, and none has been shown to provide it. When a product reaches for "detox," it has generally left the evidence behind.

When bloating deserves a workup, not a jar

Here is the part that matters most for safety, and it is the reason a registered dietitian writes this section carefully. Persistent digestive symptoms can be the surface of something a supplement will only mask. Reaching for an enzyme blend to quiet ongoing bloating, gas, or loose stools can delay a diagnosis that actually needs treatment.

Three conditions in particular hide behind "I'm just bloated." EPI itself — the real enzyme deficiency — needs that fecal elastase test and prescription PERT, not a guess.¹ Celiac disease is an autoimmune reaction to gluten that requires specific blood testing and, critically, must be tested for before you cut gluten, since stopping early muddies the result. And small intestinal bacterial overgrowth (SIBO) produces exactly the bloating and gas people self-treat with enzymes, but is driven by bacteria in the wrong place and managed differently. None of these is fixed by an over-the-counter enzyme blend, and all of them are worth ruling out when symptoms are persistent, worsening, or paired with weight loss, blood, anemia, or greasy stools.

The rule of thumb is simple: occasional, food-specific gas is a candidate for a targeted enzyme. Persistent, unexplained, or alarm-flagged symptoms are a candidate for a clinician. The cheapest, fastest enzyme product is no bargain if it postpones the workup you actually needed.

Where enzymes fit: a tiered view

It helps to place digestive enzymes honestly on a spectrum of who they're for and how settled the case is. We don't write prescriptions; we write frameworks you take to a clinician.

Essential — diagnosed deficiency. For confirmed exocrine pancreatic insufficiency, prescription PERT is established, necessary treatment with strong trial support.² This is medicine, dosed and supervised by a clinician, and it sits in a different category from everything below it.

Useful — a specific, known intolerance. If you have a defined intolerance that matches a targeted enzyme — lactase for diagnosed lactose intolerance, alpha-galactosidase for reliable bean-gas — the single-enzyme tool is a reasonable, low-risk, evidence-supported aid taken with the trigger food.³⁴ The key is specificity: you are buying the one enzyme for the one substance, not a catch-all.

Optional and unproven — broad blends for general digestion. For a healthy person with everyday bloating and no diagnosed deficiency, a broad-spectrum enzyme blend is a low-evidence experiment. It is unlikely to harm a healthy gut, but it is unlikely to do much either, and the dietary and food-trigger levers usually outperform it. If you try one, treat it as a personal n-of-1 with a clear stop date — not a daily habit you keep because the jar says "gut support."

Grey areas and open questions

The functional-dyspepsia signal needs replication. The one positive blend trial is encouraging but singular — one product, one center, one defined condition.⁵ Whether it replicates, generalizes to other products, or extends to general bloating is genuinely unknown. A single good trial is a reason to watch the space, not to endorse the shelf.

Product potency is a real unknown. Because over-the-counter blends are regulated as supplements, the enzyme activity actually delivered can differ from the label, and independent verification is inconsistent across brands. Even where an enzyme could in principle help, you can't always be sure the jar contains what it claims — which makes weak average results even harder to interpret.

Individual variation is underexplored. It is plausible that a subset of people with subclinical maldigestion — below the EPI threshold but not perfectly efficient — gets real benefit from supplemental enzymes. The trouble is we have no good way to identify them outside a formal diagnosis, so "maybe it helps some people" can't yet be turned into "here is who." Until that's mapped, the honest default for the undiagnosed is skepticism.

What this article is not saying

This is not "digestive enzymes are a scam." The opposite: for diagnosed pancreatic insufficiency they are essential, well-evidenced medicine, and for specific intolerances they are a genuinely useful, trial-supported tool. Dismissing the whole category would throw out treatment that some people truly depend on.

And this is not "the broad blends will hurt you." For a healthy person they are generally low-risk. The point is narrower and more practical: low-risk is not the same as effective, and "won't hurt" is not a reason to spend money every month on something the evidence doesn't back for your situation.

What it is saying: match the tool to a real deficit. If you have a diagnosed deficiency, replace what's missing. If you have a specific intolerance, supply the one enzyme you lack. If you have a normal gut and a vague hope of feeling lighter, the blend is mostly buying you a feeling — and persistent symptoms deserve a workup, not a jar. Read the category that way and you'll spend your money where it actually does something.